Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8528ff66470c896b6da8ed059464e31f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9499bfaa0f7c82a0a4bc86f34406d477 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91017 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
filingDate |
2018-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c5e1008412471e78d1568be355b541b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48009293283783d4032beba03bdcf716 |
publicationDate |
2020-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3692169-A1 |
titleOfInvention |
Biomarkers for neurodegenerative and/or neuromuscular diseases |
abstract |
The present invention generally relates to the diagnosis of neurodegenerative and / or neuromuscular diseases such as Charcot-Marie-Tooth's disease, in particular type 2, and is based on the discovery of 2 new biomarkers (PFN2 and GAMT), which have been shown to be downregulated in patients. |
priorityDate |
2017-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |